Citation Impact
Citing Papers
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages
2008
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
2001
In vivo phage display and vascular heterogeneity: implications for targeted medicine
2002
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2006 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Angiogenesis in primary central nervous system lymphoma (PCNSL)
2007
Clinical translation of angiogenesis inhibitors
2002 Standout
The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.
1997
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-$alpha;
2003
Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration
2007
Mast cell contribution to angiogenesis related to tumour progression
2004
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
2000
Tumor angiogenesis: past, present and the near future
2000
Two‐Photon Absorption and the Design of Two‐Photon Dyes
2009 Standout
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis
2004
The role of myeloid cells in the promotion of tumour angiogenesis
2008
Angiogenesis and antiangiogenic therapy in hematologic malignancies
2006
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma
2001
The biology and function of fibroblasts in cancer
2016 Standout
IgE and mast cells in allergic disease
2012 Standout
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
Mast cells and angiogenesis
2002
The multifaceted role of periostin in tumorigenesis
2009
Angiogenesis in cancer and other diseases
2000 StandoutNature
The biology of VEGF and its receptors
2003 Standout
Multiple myeloma
2000 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Expression of HIF‐1α by human macrophages: implications for the use of macrophages in hypoxia‐regulated cancer gene therapy
2001
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Angiogenesis in health and disease
2003 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Cancer genes and the pathways they control
2004 Standout
Mast cells and basophils: friends as well as foes in bronchial asthma?
2004
Angiogenesis-dependent diseases
2001
The development of allergic inflammation
2008 StandoutNature
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Macrophage Responses to Hypoxia
2005
Mast Cell Proteases
2007
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Vascularization and biocompatibility of scaffolds consisting of different calcium phosphate compounds
2007
Immunity, Inflammation, and Cancer
2010 Standout
Mast Cells in Lung Inflammation
2011
Inflammation and cancer: back to Virchow?
2001 Standout
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
2007
Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials
2001
Microenvironmental regulation of metastasis
2008 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
The angiogenic switch in carcinogenesis
2009
Angiogenesis is an early event in the generation of myc-induced lymphomas
2000
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
Analysis of the role of chemokines in angiogenesis
2003
The molecular characterization and clinical management of multiple myeloma in the post-genome era
2009
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The significant role of mast cells in cancer
2011
Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins αvβ3 and α6β1 in Human Umbilical Vein Endothelial Cells
2002 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Exosomes: composition, biogenesis and function
2002 Standout
Tumorigenesis and the angiogenic switch
2003 Standout
Tumor-Associated Macrophages Press the Angiogenic Switch in Breast Cancer
2007
Angiogenesis Research: Guidelines for Translation to Clinical Application
2001
Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy
2005
From Blood Monocytes to Adipose Tissue-Resident Macrophages
2004
Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
2003
Normoxic Stabilization of Hypoxia-Inducible Factor-1α by Modulation of the Labile Iron Pool in Differentiating U937 Macrophages: Effect of Natural Resistance–Associated Macrophage Protein 1
2006 StandoutNobel
Therapeutic coronary angiogenesis: a fronte praecipitium a tergo lupi?
2001
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
2003 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis
2010
Angiogenesis extent and expression of matrix metalloproteinase‐2 and ‐9 correlate with upgrading and myometrial invasion in endometrial carcinoma
1999
Multiple Myeloma
2011 Standout
Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion
2008
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Macrophage responses to hypoxia: relevance to disease mechanisms
1999
Genes Expressed in Human Tumor Endothelium
2000 StandoutScience
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
2004
Works of B Nico being referenced
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin’s lymphomas
1999
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma
1999
The history of the angiogenic switch concept
2006
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2
1999
Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti‐angiogenesis in vivo
2001
A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy
2003
Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma
2006
ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon β-1a and TNFα
1998
Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes
2002
Cell-Mediated Delivery of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor onto the Chick Chorioallantoic Membrane: Endothelial Fenestration and Angiogenesis
2001
Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma
2001
Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas
2000
Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody- dependent cellular cytotoxicity [see comments]
1996